The post Taylor Swift’s Career-Changing Single Is Back appeared on BitcoinEthereumNews.com. Taylor Swift’s “Blank Space” returns to the Billboard Global 200 at No. 199, more than a decade after its original release. THE VOICE — “Live Show” Episode 715B — Pictured: Taylor Swift — (Photo by: Tyler Golden/NBCU Photo Bank/NBCUniversal via Getty Images via Getty Images) NBCU Photo Bank/NBCUniversal via Getty Images When it comes to the Billboard charts, Taylor Swift is usually present on albums-focused rankings. Occasionally, outside of normal promotional periods, a handful of songs will find their way to a few tallies, but it’s her full-lengths that perform best week after week. It’s another huge moment for Swift on the Billboard charts, as excitement around the upcoming release of her soon-to-be-shared project The Life of a Showgirl helps multiple titles return. Again, that largely applies to albums, but one of the singer-songwriter’s most famous tunes also becomes a hit once again… though only barely. “Blank Space” Returns to the Billboard Global 200 On the Billboard Global 200, the company’s list of the most consumed songs all around the world, “Blank Space” returns. Swift’s classic, which dominated rankings worldwide more than a decade ago when it was spun off as a single from her album 1989, reenters the 200-spot ranking in second-to-last place, at No. 199. “Blank Space” Narrowly Cracked the Top 40 While “Blank Space” is counted among Swift’s most famous songs, its release preceded the introduction of Billboard’s global charts by several years. “Blank Space” has only ever climbed as high as No. 32 on the Billboard Global 200 throughout the 82 frames it has spent somewhere on the tally. Taylor Swift’s Three Global Wins Swift keeps two other tracks present on the Billboard Global 200 this week, and both of them also appear on the Billboard Global Excl. U.S., the similarly-composed ranking that excludes American streams… The post Taylor Swift’s Career-Changing Single Is Back appeared on BitcoinEthereumNews.com. Taylor Swift’s “Blank Space” returns to the Billboard Global 200 at No. 199, more than a decade after its original release. THE VOICE — “Live Show” Episode 715B — Pictured: Taylor Swift — (Photo by: Tyler Golden/NBCU Photo Bank/NBCUniversal via Getty Images via Getty Images) NBCU Photo Bank/NBCUniversal via Getty Images When it comes to the Billboard charts, Taylor Swift is usually present on albums-focused rankings. Occasionally, outside of normal promotional periods, a handful of songs will find their way to a few tallies, but it’s her full-lengths that perform best week after week. It’s another huge moment for Swift on the Billboard charts, as excitement around the upcoming release of her soon-to-be-shared project The Life of a Showgirl helps multiple titles return. Again, that largely applies to albums, but one of the singer-songwriter’s most famous tunes also becomes a hit once again… though only barely. “Blank Space” Returns to the Billboard Global 200 On the Billboard Global 200, the company’s list of the most consumed songs all around the world, “Blank Space” returns. Swift’s classic, which dominated rankings worldwide more than a decade ago when it was spun off as a single from her album 1989, reenters the 200-spot ranking in second-to-last place, at No. 199. “Blank Space” Narrowly Cracked the Top 40 While “Blank Space” is counted among Swift’s most famous songs, its release preceded the introduction of Billboard’s global charts by several years. “Blank Space” has only ever climbed as high as No. 32 on the Billboard Global 200 throughout the 82 frames it has spent somewhere on the tally. Taylor Swift’s Three Global Wins Swift keeps two other tracks present on the Billboard Global 200 this week, and both of them also appear on the Billboard Global Excl. U.S., the similarly-composed ranking that excludes American streams…

Taylor Swift’s Career-Changing Single Is Back

Taylor Swift’s “Blank Space” returns to the Billboard Global 200 at No. 199, more than a decade after its original release. THE VOICE — “Live Show” Episode 715B — Pictured: Taylor Swift — (Photo by: Tyler Golden/NBCU Photo Bank/NBCUniversal via Getty Images via Getty Images)

NBCU Photo Bank/NBCUniversal via Getty Images

When it comes to the Billboard charts, Taylor Swift is usually present on albums-focused rankings. Occasionally, outside of normal promotional periods, a handful of songs will find their way to a few tallies, but it’s her full-lengths that perform best week after week.

It’s another huge moment for Swift on the Billboard charts, as excitement around the upcoming release of her soon-to-be-shared project The Life of a Showgirl helps multiple titles return. Again, that largely applies to albums, but one of the singer-songwriter’s most famous tunes also becomes a hit once again… though only barely.

“Blank Space” Returns to the Billboard Global 200

On the Billboard Global 200, the company’s list of the most consumed songs all around the world, “Blank Space” returns. Swift’s classic, which dominated rankings worldwide more than a decade ago when it was spun off as a single from her album 1989, reenters the 200-spot ranking in second-to-last place, at No. 199.

“Blank Space” Narrowly Cracked the Top 40

While “Blank Space” is counted among Swift’s most famous songs, its release preceded the introduction of Billboard’s global charts by several years. “Blank Space” has only ever climbed as high as No. 32 on the Billboard Global 200 throughout the 82 frames it has spent somewhere on the tally.

Taylor Swift’s Three Global Wins

Swift keeps two other tracks present on the Billboard Global 200 this week, and both of them also appear on the Billboard Global Excl. U.S., the similarly-composed ranking that excludes American streams and sales. “Blank Space” only appears on the Billboard Global 200, as consumption by U.S.-based listeners largely helped fuel its return.

“Cruel Summer” Grows

“Cruel Summer” is on the rise on both worldwide rosters this week. The track steps up 17 spaces on the Billboard Global 200, landing at No. 60. At the same time, it improves by an even greater number of spots on the Billboard Global Excl. U.S., shooting from No. 90 to No. 68.

“August” Falls

After experiencing its annual surge in popularity at the beginning of the month, Swift’s “August” is on the decline. Last week, “August” appeared at No. 126 on the Billboard Global 200 and No. 153 on the Billboard Global Excl. U.S. This time around, the non-single, taken from her album Folklore, dips 10 spaces south on the Billboard Global 200 and falls to No. 167 on the Billboard Global Excl. U.S.

Source: https://www.forbes.com/sites/hughmcintyre/2025/08/31/taylor-swifts-career-changing-single-is-back/

Market Opportunity
Seed.Photo Logo
Seed.Photo Price(PHOTO)
$0.31151
$0.31151$0.31151
0.00%
USD
Seed.Photo (PHOTO) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact [email protected] for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

5 High-Growth Cryptos for 2025: BullZilla Tops the Charts as the Best 100x Crypto Presale

5 High-Growth Cryptos for 2025: BullZilla Tops the Charts as the Best 100x Crypto Presale

BullZilla, World Liberty Financial, MoonBull, La Culex, and Polkadot (DOT) are taking the spotlight among emerging and established crypto projects […] The post 5 High-Growth Cryptos for 2025: BullZilla Tops the Charts as the Best 100x Crypto Presale appeared first on Coindoo.
Share
Coindoo2025/10/18 08:15
Over $145M Evaporates In Brutal Long Squeeze

Over $145M Evaporates In Brutal Long Squeeze

The post Over $145M Evaporates In Brutal Long Squeeze appeared on BitcoinEthereumNews.com. Crypto Futures Liquidations: Over $145M Evaporates In Brutal Long Squeeze
Share
BitcoinEthereumNews2026/01/16 11:35
Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

The post Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution appeared on BitcoinEthereumNews.com. In this week’s edition of InnovationRx, we look at possible pain treatments from cannabis, risks of new vaccine restrictions, virtual clinical trials at the Mayo Clinic, GSK’s $30 billion U.S. manufacturing commitment, and more. To get it in your inbox, subscribe here. Despite their addictive nature, opioids continue to be a major treatment for pain due to a lack of effective alternatives. In an effort to boost new drugs, the FDA released new guidelines for non-opioid painkillers last week. But making these drugs hasn’t been easy. Vertex Pharmaceuticals received FDA approval for its non-opioid Journavx in January, then abandoned a next generation drug after a failed clinical trial earlier this summer. Acadia similarly abandoned a promising candidate after a failed trial in 2022. One possible basis for non-opioids might be cannabis. Earlier this year, researchers at Washington University at St. Louis and Stanford published a study showing that a cannabis-derived compound successfully eased pain in mice with minimal side effects. Munich-based pharmaceutical company Vertanical is perhaps the furthest along in this quest. It is developing a cannabinoid-based extract to treat chronic pain it hopes will soon become an approved medicine, first in the European Union and eventually in the United States. The drug, currently called Ver-01, packs enough low levels of cannabinoids (including THC) to relieve pain, but not so much that patients get high. Founder Clemens Fischer, a 50-year-old medical doctor and serial pharmaceutical and supplement entrepreneur, hopes it will become the first cannabis-based painkiller prescribed by physicians and covered by insurance. Fischer founded Vertanical, with his business partner Madlena Hohlefelder, in 2017, and has invested more than $250 million of his own money in it. With a cannabis cultivation site and drug manufacturing plant in Denmark, Vertanical has successfully passed phase III clinical trials in Germany and expects…
Share
BitcoinEthereumNews2025/09/18 05:26